Exploring novel therapeutic opportunities for hypertension: a paradigm-shifting approach via integrative multiomic analysis, pioneering the path to precision medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploring novel therapeutic opportunities for hypertension: a paradigm-shifting approach via integrative multiomic analysis, pioneering the path to precision medicine

Published:2024-05-30 Issue:7 Volume:42 Page:1147-1149
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Saluja Sushant¹²,Lennon Rachel³

Affiliation:

1. Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester

2. Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester

3. Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference32 articles.

1. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial;Schlaich;Lancet,2022

2. Drug repurposing: progress, challenges and recommendations;Pushpakom;Nat Rev Drug Discov,2019

3. How to improve R&D productivity: the pharmaceutical industry's grand challenge;Paul;Nat Rev Drug Discov,2010

4. Key concepts of clinical trials: a narrative review;Umscheid;Postgrad Med,2011

5. Accelerating drug discovery;Kraljevic;EMBO Rep,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP